RE: Just a little more patience required from shareholders, as hard as it is30 Apr 2025 12:54
As a major investor in hemo, I have been weighing up the options here as well. I feel there are multiple options on the table, some more likely that others in the timeframe we have. (1) Pharma - Not likely until 4 patients (2) VC - Possibly but this delay in p2 could delay this since most likely they want to more patients in a positive (3) Loan - Possible (4) Placing - Possible and hopefully not discounted. The key for any funding for me would be irrelevant about peterhouse or anyone else but hemo can raise enough to give it a 6 month runway if possible. This would allay any fears that money would run out again and would then prevent VCs squeezing hemo even on 2 oe 3 patients. Once Vlad has the financial runway to negotiate a proper deal and once we have 3 patients data, I strongly feel hemo will be valued properly. Until then, there will be zero interest in buying this stock so the month of May is critical for the next steps in Hemo's life